Kron A, Scheffler M, Wiesweg M, Hummel HD, Kulhavy J, Gatteloehner S, Kollmeier J, Schubart C, Groß T, Demes MC, Keymel S, Joosten M, Merkelbach-Bruse S, Woelwer CB, Tufman A, Kauffmann-Guerrero D, Oeser K, Zehaczek M, Jeratsch U, Wolf J (2024)
Publication Type: Journal article, Erratum
Publication year: 2024
Book Volume: 213
Article Number: 115074
DOI: 10.1016/j.ejca.2024.115074
The authors removed the study acronym ‘RECAP’ throughout the article. The authors would like to add the following to acknowledgement section of the publication.
APA:
Kron, A., Scheffler, M., Wiesweg, M., Hummel, H.D., Kulhavy, J., Gatteloehner, S.,... Wolf, J. (2024). Corrigendum to “Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations” [Eur J Cancer 207 (2024) 114158](S0959804924008141)(10.1016/j.ejca.2024.114158). European Journal of Cancer, 213. https://doi.org/10.1016/j.ejca.2024.115074
MLA:
Kron, Anna, et al. "Corrigendum to “Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations” [Eur J Cancer 207 (2024) 114158](S0959804924008141)(10.1016/j.ejca.2024.114158)." European Journal of Cancer 213 (2024).
BibTeX: Download